Our Impact
SeVA will continuously interact with patients to promote social interaction, engage them to reduce loneliness, and as such, prevent subsequent delirium episodes with this cognitive encouragement. All available competitor medical devices, either in the development phase or already in the market, are instruments for diagnosis (with varying levels of accuracy). SeVA is both diagnostic and therapeutic, i.e., post-diagnosis of delirium, it will also employ non-pharmacological methods to prevent future episodes. This aspect and functionality of SeVA technology will result in a significant reduction in resource utilization for hospitals and other care entities.
The SeVA platform will free up nursing time to perform timely checks on the patient and therefore will provide time to nurses for more hands-on actionable care, rather than spend time in assessments. Nursing teams can optimize their time towards patient care with SeVA’s technology.
SeVA platform will result in a significant reduction in extra-hospital days and consequently this results in a cumulative cost-saving potential anywhere between $ 32 Billion to $ 80 Billion a year.
SeVA platform will provide continuous monitoring of patient conditions and can immediately report medical emergency events to the care team (doctors) for intervention. This will significantly improve the quality of healthcare and save lives due to the immediate alert notification capability of SeVA technology.
